Research Associate Professor, Epidemiology
EducationPhD Epidemiology, University of Washington, 1996
MPH Epidemiology, Yale University, 1991
Division of Public Health Sciences, Epidemiology Program
1100 Fairview Ave N., Building M
PO Box 19024, Mailstop: M4-C313
Seattle, WA 98109
Margaret M. Madeleine, MPH, PhD, is a Research Associate Professor in the Department of Epidemiology in the School of Public Health at the University of Washington and an Associate Member, Program in Epidemiology, Fred Hutchinson Cancer Research Center. She received her MPH in Epidemiology from Yale in 1991 and PhD from UW in 1996. She began her Epi career as a Staff Scientist at the Fred Hutch, and was the project director for case-control studies of HPV-related cancers. She has been a key member of the Seattle HPV research group.
Dr. Madeleine’s research focuses on the epidemiology of infection-related cancer, especially HPV-related cancers and pre-cancerous lesions. She has led studies that examine the immunogenetics of HPV-related cervical and vulvar neoplasia, with a focus on HLA alleles, and continues to follow up on that work as a leader in the International Cervical Cancer Consortium. She recently completed a cohort study on Skin Cancer after Organ Transplant (the SCOT study), which examined the role of cutaneous HPV in non-melanoma skin cancer.
Dr. Madeleine's major research focus is on the molecular epidemiology of pathogens and our immune response to them that may be associated with cancer development and prognosis. She is interested in the common drivers behind the role that chronic subclinical inflammation (such as occurs with age, viral infection, and UV exposure) plays in cancer.
Dr. Madeleine teaches EPI 540 "Introduction to Cancer Biology" in spring quarter of even years. She also teaches Epi 524 Cancer: Epidemiology and Biology.
In The News
Indoor Tanning, Melanoma on the Rise in Young, White Women
Petri Dish blog, 08/21/2013
Experts Warn of Skin Cancer Risk, Urge Sunscreen During Morning Routine
Research Team Honored for Innovative Science to Advance Cancer Research